Low molecular weight heparin therapy during pregnancy is associated with elevated circulatory levels of placental growth factor

Y. Yinon*, E. Ben Meir, L. Margolis, S. Lipitz, E. Schiff, S. Mazaki-Tovi, M. J. Simchen

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

39 Scopus citations

Fingerprint

Dive into the research topics of 'Low molecular weight heparin therapy during pregnancy is associated with elevated circulatory levels of placental growth factor'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science